Skip to Main Content

Paper Details

PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.
Eur Urol Focus
54
2016
ERG, ERG gene, PARTICIPANTS, PATIENT, PCa, PTEN, PTEN tumor, PTEN tumor suppressor gene, Prostate Cancer, patients, primary prostate tumors, prostate cancer, prostate tumors, tumor, tumor suppressor gene, tumors
Author NameAffiliation
Tamara L LotanJohns Hopkins School of Medicine
Ladan Fazli
Antonio Hurtado-Coll
Dean A TroyerEastern Virginia Medical School
Martin E Gleave
Raymond S LanceEastern Virginia Medical School
Daniel W LinUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Ian M ThompsonUniversity of Texas Health Science Center
Lawrence D TrueUniversity of California-San Francisco
  • 1 - 11

Datasets

Release 1.2